Expert Opinion on Drug Metabolism & Toxicology

Papers
(The H4-Index of Expert Opinion on Drug Metabolism & Toxicology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The Central Role of Cytochrome P450 Reductase (CPR) in Hyperoxic Lung Injury107
Pharmacokinetic evaluation of bictegravir + emtricitabine + tenofovir alafenamide in HIV treatment98
The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress65
A three-arm clinical study to compare pharmacokinetic and pharmacodynamic similarity of the denosumab biosimilar LY06006 with reference denosumab in healthy male subjects57
Preventable serious drug-disease interactions of reserve antibiotics55
Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations49
Population toxicokinetics of carbamazepine and its metabolite carbamazepine-10,11-epoxide in adults44
Review and evaluation of vancomycin dosing guidelines for obese individuals35
Biomarkers of 4-hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) intake identified from human hepatocyte incubations32
Optimizing therapeutic drug monitoring in inflammatory bowel disease: a focus on therapeutic monoclonal antibodies31
A pharmacokinetic evaluation of tenapanor for the treatment of irritable bowel syndrome with constipation: an update of the literature29
Drug-drug interactions between COVID-19 drug therapies and antidepressants27
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications25
A systematic review on the clinical pharmacokinetics of vildagliptin in healthy and disease populations24
Predicting the pharmacokinetics and pharmacodynamics of antisense oligonucleotides: an overview of various approaches and opportunities for PBPK/PD modelling21
Induction effect of antiretroviral bictegravir on the expression of Abcb1, Abcg2 and Abcc1 genes associated with P-gp, BCRP and MRP1 transporters present in rat peripheral blood mononuclear cells21
An update on microfluidic multi-organ-on-a-chip systems for reproducing drug pharmacokinetics: the current state-of-the-art20
Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine18
Comorbidities and the right dose: antipsychotics18
The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update18
0.5492889881134